| 1601 |
7926420 | [Insulin resistance: an etiological factor in essential arterial hypertension and coronary cardiopathy]. | 1993 Sep-Oct |
1 |
| 1602 |
8112499 | Metformin--an update. | 1993 Nov |
1 |
| 1603 |
8158383 | Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives. | 1993 Dec |
1 |
| 1604 |
8222336 | Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin dependent diabetic patients and effects of metformin. | 1993 Sep |
1 |
| 1605 |
8339856 | Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects. | 1993 Mar-Apr |
1 |
| 1606 |
8387542 | Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. | 1993 May |
2 |
| 1607 |
8412779 | The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. | 1993 Sep |
2 |
| 1608 |
8453955 | Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. | 1993 |
6 |
| 1609 |
8462390 | Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. | 1993 Apr |
1 |
| 1610 |
8475636 | [Combination therapy of oral antidiabetic drugs with insulin]. | 1993 Mar |
1 |
| 1611 |
1505458 | Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. | 1992 Sep |
1 |
| 1612 |
1523352 | Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes. | 1992 Jan-Mar |
2 |
| 1613 |
1543016 | Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro. | 1992 Feb |
7 |
| 1614 |
1551495 | Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. | 1992 Mar |
5 |
| 1615 |
1569149 | Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control. | 1992 May |
1 |
| 1616 |
1583082 | Metformin and blood pressure. | 1992 Apr |
3 |
| 1617 |
1600835 | Biguanides and NIDDM. | 1992 Jun |
2 |
| 1618 |
1752350 | Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. | 1991 Sep-Oct |
1 |
| 1619 |
1759920 | Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus. | 1991 Oct |
2 |
| 1620 |
1773025 | Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). | 1991 |
2 |
| 1621 |
1788832 | Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and antidiabetic drugs. | 1991 Nov 15 |
1 |
| 1622 |
1834486 | The insulin sparing effect of metformin in insulin-treated diabetic patients. | 1991 May |
3 |
| 1623 |
1900072 | Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. | 1991 Feb |
3 |
| 1624 |
1916049 | Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. | 1991 Jul |
2 |
| 1625 |
1936473 | Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. | 1991 May |
1 |
| 1626 |
1936475 | Management of type 2 diabetes mellitus with special reference to metformin therapy. | 1991 May |
3 |
| 1627 |
1936478 | Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. | 1991 May |
5 |
| 1628 |
1936479 | Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes. | 1991 May |
1 |
| 1629 |
1936485 | BIGPRO (biguanides and the prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin resistance. | 1991 May |
2 |
| 1630 |
1955512 | Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. | 1991 Dec |
1 |
| 1631 |
2086278 | Diurnal pattern of plasma metformin concentrations and its relation to metabolic effects in type 2 (non-insulin-dependent) diabetic patients. | 1990 Dec |
3 |
| 1632 |
2191888 | Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients. | 1990 Jul |
1 |
| 1633 |
2198745 | Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations. | 1990 Apr-Jun |
2 |
| 1634 |
2258095 | [Bedtime administration of metformin may reduce insulin requirements]. | 1990 Oct |
1 |
| 1635 |
2523787 | The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes. | 1989 Apr |
1 |
| 1636 |
2648723 | Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. | 1989 Mar |
2 |
| 1637 |
2702918 | Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics. | 1989 Jan 3 |
1 |
| 1638 |
3075902 | Treatment--metformin. | 1988 May |
2 |
| 1639 |
3149105 | Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy. | 1988 Jul-Sep |
1 |
| 1640 |
3239906 | [Lipoatrophic diabetes with insulin resistance controlled by metformin]. | 1988 |
1 |
| 1641 |
3115843 | Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. | 1987 Jul |
3 |
| 1642 |
3126223 | Effects of metformin and glibenclamide on insulin receptors in fibroblasts and tumor cells in vitro. | 1987 Dec |
5 |
| 1643 |
3310318 | Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. | 1987 Jun 3 |
1 |
| 1644 |
3329125 | [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics]. | 1987 Nov-Dec |
1 |
| 1645 |
3552509 | Role of metformin in treatment of diabetes mellitus. | 1987 Jan-Feb |
3 |
| 1646 |
3552515 | Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. | 1987 Jan-Feb |
5 |
| 1647 |
3552772 | Metformin enhances insulin binding to "in vitro" down regulated human fat cells. | 1987 Feb |
9 |
| 1648 |
3552795 | Mechanism of metformin action in non-insulin-dependent diabetes. | 1987 May |
1 |
| 1649 |
3533670 | Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. | 1986 Aug |
3 |
| 1650 |
3745404 | Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. | 1986 Oct |
2 |